Pneumonia News and Research

RSS
Pneumonia is a leading cause of death and hospitalization, costing health care systems billions of dollars and an estimated 600,000 adult deaths worldwide each year. Pneumococcal disease is caused by the bacterium Streptococcus pneumoniae and the term describes a group of illnesses, including invasive infections, such as bacteremia/sepsis and meningitis, as well as pneumonia and upper respiratory tract infections. Although all age groups may be affected, the highest rate of pneumococcal disease occurs in young children and older adults. In addition, persons suffering from a wide range of chronic conditions (eg, diabetes, cardiovascular disease) and immune deficiencies are at increased risk.
Scientists develop lab-grown lung model to study SARS-CoV-2 infection

Scientists develop lab-grown lung model to study SARS-CoV-2 infection

Researchers develop "mini lungs" to study SARS-CoV-2 infection

Researchers develop "mini lungs" to study SARS-CoV-2 infection

Scientists identify molecular mechanisms of IFN responses in COVID-19 disease

Scientists identify molecular mechanisms of IFN responses in COVID-19 disease

Researchers identify specific cellular pathway involved in the regeneration of lung tissue

Researchers identify specific cellular pathway involved in the regeneration of lung tissue

Researchers discover how antibiotic resistance genes spread via plasmids

Researchers discover how antibiotic resistance genes spread via plasmids

Druggable pocket in SARS-CoV-2 Spike protein can help eliminate COVID-19

Druggable pocket in SARS-CoV-2 Spike protein can help eliminate COVID-19

Researchers review the role of macrophage activation syndrome in COVID-19

Researchers review the role of macrophage activation syndrome in COVID-19

Researchers identify an effective treatment for severe cases of COVID-19 infection

Researchers identify an effective treatment for severe cases of COVID-19 infection

Researchers describe new approach involving "antivitamins" to develop new antibiotics

Researchers describe new approach involving "antivitamins" to develop new antibiotics

Researchers find associations of lifelong antimicrobial drug use with saliva microbiota diversity

Researchers find associations of lifelong antimicrobial drug use with saliva microbiota diversity

Study may point to new therapeutic options for COVID-19

Study may point to new therapeutic options for COVID-19

Synthetic peptide makes multidrug-resistant bacteria sensitive to antibiotics

Synthetic peptide makes multidrug-resistant bacteria sensitive to antibiotics

AI can be used as a supplementary tool for identifying causal pathogens of pneumonia

AI can be used as a supplementary tool for identifying causal pathogens of pneumonia

Type 1 interferon deficiency in the blood could be a hallmark of severe COVID-19

Type 1 interferon deficiency in the blood could be a hallmark of severe COVID-19

Keck Medicine of USC participates in clinical trial to test antiviral drug as potential COVID-19 treatment

Keck Medicine of USC participates in clinical trial to test antiviral drug as potential COVID-19 treatment

Researchers explore the reproduction of adenoviruses in cells

Researchers explore the reproduction of adenoviruses in cells

Researchers evaluate role of zinc in COVID-19 prevention

Researchers evaluate role of zinc in COVID-19 prevention

Single dose of tocilizumab improves survival in critically ill COVID-19 patients

Single dose of tocilizumab improves survival in critically ill COVID-19 patients

Relationship between COVID-19 and food safety, biosecurity

Relationship between COVID-19 and food safety, biosecurity

Potent human antibodies protect against SARS-CoV-2 in animal tests

Potent human antibodies protect against SARS-CoV-2 in animal tests